logo image
search icon
Global Implantable Neurostimulators Market

Implantable Neurostimulators Market Size, Share & Trends Analysis Report By Product (Peripheral Nerve Stimulation, Myostimulation, Spinal Cord Stimulation, and Brain Stimulation), By Application, By End-Users, Region And Segment Forecasts, 2023-2031.

Report ID : 1167 | Published : 2024-04-01 | Pages: 190 | Format: PDF/EXCEL

The Implantable Neurostimulators Market Size is valued at 5909.5 Million in 2022 and is predicted to reach 16830.6 Million by the year 2031 at a 12.40 % CAGR during the forecast period for 2023-2031.

Implantable Neurostimulators Market

The Implantable Neurostimulators are the surgically located devices that deliver slight electrical signals to the epidural space nearby the spine through leads. These devices are used to modify the nervous system to advance biological functions. The action involves the modulation of electrical signs moved from the brain to other organs and vice versa. Neurostimulators are implanted among patients who do not obtain relief from invasive surgical therapy and standard drugs. The growth of the implantable neurostimulators market is driven mainly by advancements in technology, cumulative age-related nervous disorders, growing awareness, long-term cost-effectiveness, and improved clinical outcomes. Moreover, the growing FDA approval for implanted neurostimulators and the huge influx of new companies investing in the market is anticipated to propel the growth of the market globally.

Market Segmentation

The Implantable Neurostimulators market is a segment based on product, application, end-user, and geography. The global implantable neurostimulators market is segmented into peripheral nerve stimulation, myostimulation, spinal cord stimulation, and brain stimulation based on product type. The peripheral nerve stimulation segment is further segmented into perineal nerve stimulation, vagus nerve stimulation, and sacral nerve stimulation. The myostimulation includes gastric stimulation and upper airway stimulation. The brain stimulation products include responsive brain stimulation and deep brain stimulation. In terms of market share, spinal cord stimulation and brain stimulation are estimated to account for a significant share in the global market in 2019. The growing prevalence of epilepsy, Parkinson’s diseases, etc. are propelling the growth of segments in the global market. The Application segment comprises Pain Management, Parkinson’s Disease, Urinary and Fecal Incontinence, Epilepsy, Gastroparesis, and Others.

Based on end-user, the global implantable neurostimulators market is segmented into hospitals, specialty clinics, and ambulatory surgical centres. In 2019, the hospitals dominated the global market in terms of revenue share. The presence of well-equipped hospitals and the availability of reimbursement schemes at hospitals are contributing to the high share of the segment in the global market.

Based on geography, the Global Implantable Neurostimulators Market has been segmented into North America, Asia Pacific, Latin America, Europe, and Middle East & Africa. In terms of revenue, North America is accounted for the largest share in the Global Implantable Neurostimulators market in 2019. The high adoption of technically advanced products, well-established healthcare infrastructure, and high government support are some of the major factors contributing to the high share of the market in the region. Additionally, the growing demand for minimally invasive surgeries in the region is expected to propel the growth of the North America implantable neurostimulators market over the estimated timeframe.

Competitive Landscape

Some of The Key Players in The Implantable Neurostimulators Market:

  • Axonics Modulation Technologies
  • Cyberonics
  • EnteroMedics
  • Imthera
  • Inspire Medical
  • IntraPace
  • LivaNova
  • Medtronic
  • NeuroPace
  • Nevro Corp.
  • Nuvectra
  • SPR Therapeutics
  • Stimwave
  • Other Prominent Players

The Implantable Neurostimulators Market Report Scope

Report Attribute

Specifications

Market Size Value In 2022

USD 5300.0 Million

Revenue Forecast In 2031

USD 16830.6 Million

Growth Rate CAGR

CAGR of 12.40 % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million, Volume (Unit), and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Product, By Application, By End-Users

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Cyberonics, EnteroMedics, Axonics Modulation Technologies, Imthera, IntraPace, LivaNova, Medtronic, Inspire Medical, NeuroPace, Nevro Corp., SPR Therapeutics, Nuvectra, and Stimwave, among others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Implantable Neurostimulators Market Snapshot

Chapter 4. Global Implantable Neurostimulators Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Market Dynamics - Drivers

4.3. Challenges/Restraints

4.4. Market Trends

4.5. Industry Analysis – Porter’s Five Forces Analysis

4.6. Competitive Landscape & Market Share Analysis

4.7. Global Epidemiology Analysis by Key Country 2019

Chapter 5. Market Segmentation 1: Product Type Estimates & Trend Analysis

5.1. Product Type & Market Share, 2019 & 2031

5.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2022 to 2031 for the following Product Type:

5.2.1. Myostimulation

5.2.1.1. Upper Airway Stimulation

5.2.1.2. Gastric Stimulation

5.2.2. Peripheral Nerve Stimulation

5.2.2.1. Vagus Nerve Stimulation

5.2.2.2. Perineal Nerve Stimulation

5.2.2.3. Sacral Nerves Stimulation

5.2.3. Spinal Cord Stimulation

5.2.4. Brain Stimulation

5.2.4.1. Deep Brain Stimulation

5.2.4.2. Responsive Brain Stimulation

Chapter 6. Implantable Neurostimulators Market Segmentation 2: Application Estimates & Trend Analysis

6.1. End-user Analysis & Market Share, 2019 & 2031

6.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2022 to 2031 for the following End-user:

6.2.1. Pain Management

6.2.2. Parkinson’s Disease

6.2.3. Urinary and Fecal Incontinence

6.2.4. Epilepsy

6.2.5. Gastroparesis

6.2.6. Others

Chapter 7. Implantable Neurostimulators Market Segmentation 3: End-user Estimates & Trend Analysis

7.1. End-user Analysis & Market Share, 2019 & 2031

7.2. Market Size (Value & Volume) & Forecasts and Trend Analyses, 2022 to 2031 for the following End-user:

7.2.1. Hospitals

7.2.2. Ambulatory Surgery Centers

7.2.3. Specialty Clinics

Chapter 8. Implantable Neurostimulators Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2023-2031

8.1.1. North America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2023-2031

8.1.2. North America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2023-2031

8.1.3. North America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by country, 2023-2031

8.1.3.1. U.S.

8.1.3.2. Canada

8.2. Europe

8.2.1. Europe Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2023-2031

8.2.1. Europe Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2023-2031

8.2.2. Europe Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2023-2031

8.2.3. Europe Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) by country, 2023-2031

8.2.3.1. Germany

8.2.3.2. Poland

8.2.3.3. France

8.2.3.4. Italy

8.2.3.5. Spain

8.2.3.6. UK

8.2.3.7. Rest of Europe

8.3. Asia Pacific

8.3.1. Asia Pacific Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2023-2031

8.3.1. Asia Pacific Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2023-2031

8.3.2. Asia Pacific Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2023-2031

8.3.3. Asia Pacific Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) by country, 2023-2031

8.3.3.1. China

8.3.3.2. India

8.3.3.3. Japan

8.3.3.4. Australia

8.3.3.5. Rest of Asia Pacific

8.4. Latin America

8.4.1. Latin America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2023-2031

8.4.1. Latin America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2023-2031

8.4.2. Latin America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2023-2031

8.4.3. Latin America Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2023-2031

8.4.3.1. Brazil

8.4.3.2. Rest of Latin America

8.5. MEA

8.5.1. MEA Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Product Type, 2023-2031

8.5.1. MEA Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by Application, 2023-2031

8.5.2. MEA Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) estimates and forecasts by End-user, 2023-2031

8.5.3. MEA revenue Implantable Neurostimulators Market revenue (US$ Million) and volume (No. of Units) by country, (US$ Million) 2023-2031

8.5.3.1. South Africa

8.5.3.2. Rest of MEA

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Axonics Modulation Technologies

9.2.2. Cyberonics

9.2.3. EnteroMedics

9.2.4. Imthera

9.2.5. Inspire Medical

9.2.6. IntraPace

9.2.7. LivaNova

9.2.8. Medtronic

9.2.9. NeuroPace

9.2.10. Nevro Corp.

9.2.11. Nuvectra

9.2.12. SPR Therapeutics

9.2.13. Stimwave

9.2.14. List of Other Prominent Players

 

Global Implantable Neurostimulators Market Segmentation:

Global Implantable Neurostimulators Market Outlook (Value (US$ Mn) & Volume (no. of units), 2019 – 2030) By Product Type

  • Myostimulation
    • Upper Airway Stimulation
    • Gastric Stimulation
  • Peripheral Nerve Stimulation
    • Vagus Nerve Stimulation
    • Perineal Nerve Stimulation
    • Sacral Nerves Stimulation
  • Spinal Cord Stimulation
  • Brain Stimulation
    • Deep Brain Stimulation
    • Responsive Brain Stimulation

Implantable Neurostimulators Market

Global Implantable Neurostimulators Market Outlook (Value (US$ Mn), By Application

  • Pain Management
  • Parkinson’s Disease
  • Urinary and Fecal Incontinence
  • Epilepsy
  • Gastroparesis
  • Others

Global Implantable Neurostimulators Market Outlook (Value (US$ Mn), By End-user

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialty Clinics

Global Implantable Neurostimulators Market Outlook (Value (US$ Mn) & Volume (no. of units), By Region

Europe

  • Germany
  • Poland
  • France
  • Italy
  • Spain
  • UK
  • Rest of Europe

North America

  • U.S.
  • Canada

Asia Pacific

  • China
  • India
  • Japan
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Rest of Latin America

Middle East & Africa

  • South Africa
  • Rest of Middle East & Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Implantable Neurostimulators Market Size ?

The Implantable Neurostimulators Market is expected to grow at a 12.40 % CAGR during the forecast period for 2023-2031.

Cyberonics, EnteroMedics, Axonics Modulation Technologies, Imthera, IntraPace, LivaNova, Medtronic, Inspire Medical, NeuroPace, Nevro Corp., SPR Thera

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4182
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach